EGFR and gastric cancer: In addition, several disease pathways including the ‘endometrial cancer, ‘colorectal cancer’, ‘ErbB signaling’, ‘breast cancer’, and ‘gastric cancer’ pathways with Kras, Gsk3b, and Raf1 genes were significantly enriched (Table 3).